Article (Scientific journals)
Effect of a 4-Week Treatment with Theophylline on Sputum Eosinophilia and Sputum Eosinophil Chemotactic Activity in Steroid-Naive Asthmatics
Louis, Renaud; Bettiol, J.; Cataldo, Didier et al.
2000In Clinical and Experimental Allergy, 30 (8), p. 1151-60
Peer Reviewed verified by ORBi
 

Files


Full Text
Effect of a 4_week treatment with theophylline on sputum oesinophilia and..._Louis_00_ClinExpAllergy.pdf
Publisher postprint (221.19 kB)
Request a copy
Full Text Parts
Effect of a 4_week treatment with theophylline on sputum oesinophilia and..._Louis_00_ClinExpAllergy.pdf
Author postprint (144.72 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Asthma; theophylline; eosinophils; chemotaxis
Abstract :
[en] BACKGROUND: The precise mechanism of action of theophylline in asthma is not fully understood but recent data have drawn attention to its potential anti-inflammatory effect. OBJECTIVE: The purpose of this study was to assess the effect of theophylline on sputum eosinophilia and sputum eosinophil chemotactic activity in steroid-naive asthmatics. METHOD: We performed a 4-week randomized double-blind, placebo-controlled, parallel group study in 21 mild to moderate steroid-naive asthmatics whose sputum eosinophilia was found twice > 5% during the run in period. Eleven subjects received 600 mg/24 h theophylline for the first 2 weeks and 900 mg/24 h for the last 2 weeks while 10 subjects took a placebo for 4 weeks. Sputum was induced after 2 and 4 weeks of treatment and 1 week after stopping the treatment. The sputum samples were compared for their cell counts, eosinophil cationic protein (ECP) levels and eosinophil chemotactic activity using micro-Boyden chambers. RESULTS: Serum theophylline concentrations reached 7 and 11 microg/mL at V3 and V4, respectively. Intragroup comparisons showed that theophylline, but not placebo, caused a significant reduction in sputum eosinophil counts at V3 (62 +/- 10% from baseline, P < 0.01) and a strong trend at V4 (67 +/- 16% from baseline, P = 0.07) when compared to baseline. The intergroup difference obtained after comparing the area under the curve over the 4 week treatment period only approached the statistical significance (P = 0.08). At baseline the fluid phase of the sputum contained a significant eosinophil chemotactic activity which was inhibited after a 4-week treatment by theophylline (P < 0. 01) but not by placebo. The mean sputum theophylline levels after 4 weeks of treament (1.7 microg/mL) was lower than that required to cause significant inhibition of eosinophil chemotaxis in vitro. CONCLUSION: Theophylline decreases the natural sputum eosinophil chemotactic activity present in asthmatics. However, when using a small sample size, the 35% reduction in sputum eosinophilia achieved by theophylline failed to reach statistical significance when compared to that seen after placebo.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Louis, Renaud ;  Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Bettiol, J.
Cataldo, Didier  ;  Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement - Département des sciences biomédicales et précliniques
Sele, Jocelyne ;  Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Henquet, M.
Radermecker, Maurice ;  Université de Liège - ULiège > Pneumologie-Allergologie
Language :
English
Title :
Effect of a 4-Week Treatment with Theophylline on Sputum Eosinophilia and Sputum Eosinophil Chemotactic Activity in Steroid-Naive Asthmatics
Publication date :
August 2000
Journal title :
Clinical and Experimental Allergy
ISSN :
0954-7894
eISSN :
1365-2222
Publisher :
Blackwell Publishing, Oxford, United Kingdom
Volume :
30
Issue :
8
Pages :
1151-60
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 10 November 2009

Statistics


Number of views
86 (4 by ULiège)
Number of downloads
195 (1 by ULiège)

Scopus citations®
 
18
Scopus citations®
without self-citations
14
OpenCitations
 
12

Bibliography


Similar publications



Contact ORBi